Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Healthy Extracts's Enterprise Value for the quarter that ended in Mar. 2026 was $29.08 Mil.
Healthy Extracts's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.96 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthy Extracts EV-to-EBIT Related Terms
Healthy Extracts EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Healthy Extracts's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Healthy Extracts's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healthy Extracts EV-to-EBIT vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Healthy Extracts's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Healthy Extracts's EV-to-EBIT falls into.
Healthy Extracts's current Enterprise Value is $22.29 Mil.
Healthy Extracts's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.96 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthy Extracts (HYEX) has a EV-to-EBIT of -23.17 as of Aug. 12, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Healthy Extracts and its competitors. According to the industry distribution chart, Healthy Extracts ranks #999999 out of 681 companies in the Drug Manufacturers industry.
Is Healthy Extracts' EV-to-EBIT too high?
Healthy Extracts' current EV-to-EBIT is -23.17. Based on the distribution chart, Healthy Extracts ranks #999999 out of 681 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Healthy Extracts has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthy Extracts' EV-to-EBIT compare to CABR and BFRI?
According to the Drug Manufacturers industry distribution chart, Healthy Extracts ranks #999999 out of 681 companies for EV-to-EBIT. This places Healthy Extracts in the lower half of its industry. The industry median EV-to-EBIT is 15.99. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Drug Manufacturers company?
The median EV-to-EBIT among Drug Manufacturers companies is 15.99, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Healthy Extracts and its competitors. For the Drug Manufacturers industry, the median EV-to-EBIT is 15.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healthy Extracts's current EV-to-EBIT is -23.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthy Extracts stock overvalued right now?
Based on GuruFocus' analysis, Healthy Extracts (HYEX) is currently considered Modestly Undervalued. The stock's GF Value™ is $1.62, compared to a current price of $1.35 — trading 16.7% below its estimated fair value. The current EV-to-EBIT is -23.17. Healthy Extracts' overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Healthy Extracts (HYEX), the current EV-to-EBIT is -23.17 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healthy Extracts (HYEX) Overvalued in 2026?
Based on GuruFocus' analysis, Healthy Extracts stock appears to be undervalued.
The current stock price of $1.35 is trading 16.7% below its estimated GF Value™ of $1.62.
GuruFocus considers Healthy Extracts to be Modestly Undervalued.
Key valuation signals for HYEX:
EV-to-EBIT: -23.17
GF Value™: $1.62 vs. price of $1.35 (16.7% below fair value)
No single metric tells the full story. See the HYEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healthy Extracts Inc through its subsidiaries is engaged in proprietary research and development of natural plant-based formulations, manufacturing, sales, and distribution of cardiovascular and neuro products that provide natural brain solutions. The company also provides superfruit supplements to support overall cholesterol, metabolic and cardiovascular health. Its products are distributed in the United States and Mexico. Its operating segment includes, Health Supplements and Corporate. The company generates maximum revenue from the Health Supplements segment.
63GF Score
Get the complete analysis for HYEX
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HYEX has been successfully added to your 
